Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa Innao

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Biomed Research International|July 28, 2020
Altered Long Noncoding RNA Expression Profile in Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the JawAlessandro Allegra, Manuela Mania, Angela D'Ascola, et al.
Archives of Medical Science : AMS|May 20, 2022
Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myelomaAlessandro Allegra, Vincenzo Rizzo, Vanessa Innao, et al.
Investigative Ophthalmology & Visual Science|May 14, 2016
Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal GammopathiesPasquale Aragona, Alessandro Allegra, Elisa Imelde Postorino, et al.
Expert Review of Hematology|June 29, 2019
Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trialsMassimo Martino, Marco Rossi, Anna Ferreri, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|April 23, 2021
A multivariate analysis of Multiple Myeloma subtype plasma cellsMartina Bonsignore, Sebastiano Trusso, Claudia De Pasquale, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 22, 2026
First-Line Treatment of Chronic Lymphocytic Leukemia in Italy: Real-World Evidence on Utilization, Outcomes, and Healthcare CostsValentina Perrone, Vanessa Innao, Stefania Mazzoni, et al.
Blood Advances|May 27, 2020
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 moleculesChiara Barberi, Claudia De Pasquale, Alessandro Allegra, et al.
Drugs in Context|March 21, 2024
Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiencesBernardo Rossini, Nicola Cecchi, Felice Clemente, et al.
In Vivo (Athens, Greece)|September 1, 2019
Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose ImatinibStefania Stella, Elena Tirró, Michele Massimino, et al.
Frontiers in Oncology|March 25, 2021
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life SurveyUros Markovic, Alessandra Romano, Vittorio Del Fabro, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Biomed Research International|July 28, 2020
Altered Long Noncoding RNA Expression Profile in Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the JawAlessandro Allegra, Manuela Mania, Angela D'Ascola, et al.
Archives of Medical Science : AMS|May 20, 2022
Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myelomaAlessandro Allegra, Vincenzo Rizzo, Vanessa Innao, et al.
Investigative Ophthalmology & Visual Science|May 14, 2016
Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal GammopathiesPasquale Aragona, Alessandro Allegra, Elisa Imelde Postorino, et al.
Expert Review of Hematology|June 29, 2019
Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trialsMassimo Martino, Marco Rossi, Anna Ferreri, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|April 23, 2021
A multivariate analysis of Multiple Myeloma subtype plasma cellsMartina Bonsignore, Sebastiano Trusso, Claudia De Pasquale, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 22, 2026
First-Line Treatment of Chronic Lymphocytic Leukemia in Italy: Real-World Evidence on Utilization, Outcomes, and Healthcare CostsValentina Perrone, Vanessa Innao, Stefania Mazzoni, et al.
Blood Advances|May 27, 2020
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 moleculesChiara Barberi, Claudia De Pasquale, Alessandro Allegra, et al.
Drugs in Context|March 21, 2024
Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiencesBernardo Rossini, Nicola Cecchi, Felice Clemente, et al.
In Vivo (Athens, Greece)|September 1, 2019
Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose ImatinibStefania Stella, Elena Tirró, Michele Massimino, et al.
Frontiers in Oncology|March 25, 2021
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life SurveyUros Markovic, Alessandra Romano, Vittorio Del Fabro, et al.
Pageof 7